The Navy’s New Stance on Steroid Use Among Special Warfare Troops

[UG]

The use of performance-enhancing drugs (PEDs) in military forces, particularly in special operations units, has long been a contentious issue. As of November 2023, the U.S. Navy is taking decisive action to mitigate the risks associated with PED use among its elite special warfare troops, including Navy SEALs and Special Warfare Combatant-Craft Crewmen (SWCC). This initiative is both a health measure and a move to maintain the integrity of the force.

Why the Navy Is Testing SEALs for Steroids​

The demand for physical and mental endurance in special operations forces is unprecedented. Missions undertaken by Navy SEALs are often physically grueling and mentally taxing, pushing operators to their limits. Some within these ranks may turn to steroids and other PEDs to enhance performance and endure the extreme rigors of their duties.

However, the Navy recognizes that PEDs, especially steroids, carry significant risks. These drugs can cause long-term health issues, undermine team trust, and threaten the Navy’s commitment to maintaining the highest standards of readiness and performance. Therefore, to protect both the individuals and the integrity of the force, the Navy is introducing random testing as a proactive measure against PED abuse.

The Significance of Random Testing​

Unlike targeted testing, random testing provides a broader scope of enforcement. By selecting units at random, the Navy ensures that all members, regardless of rank or position, are subject to testing. This approach deters PED use by increasing the unpredictability of enforcement, signaling to all members that drug use will not be tolerated.

In particular, Navy SEAL candidates and active-duty members will face stricter oversight, with testing conducted monthly across randomly selected units. The Navy’s decision is grounded in the desire to protect personnel from the dangers of steroids while upholding the reputation of the force.

Health and Performance Risks of Steroid Use in Special Warfare​

Steroids, though widely recognized for their performance-enhancing capabilities, carry a host of health risks, especially when used improperly or without medical supervision. Long-term use can result in severe physical and psychological consequences, including but not limited to:

• Heart Problems: Increased risk of heart attacks and strokes.
• Liver Damage: Steroids are processed through the liver, increasing the potential for liver failure and tumors.
• Hormonal Imbalances: Steroid use can disrupt the body’s natural hormone production, leading to infertility, shrunken testicles, and gynecomastia.
• Psychological Effects: Heightened aggression, mood swings, and depression are common among steroid users.

For members of special operations forces, the use of these drugs could compromise not only their health but also their ability to function effectively in high-stress environments. The mental sharpness, emotional stability, and cardiovascular fitness required for mission success may all be undermined by the adverse effects of steroids.

The Navy’s Testing Procedures​

The Navy’s random testing protocol will be comprehensive and rigorous, ensuring that PED use is detected effectively. Each selected sailor will be required to provide two urine samples. These samples will undergo specialized testing at two separate labs:

1. Sports Medicine Research and Testing Laboratory (SMRTL): This facility, which also tests athletes in international competitions, will screen for PEDs and advanced doping techniques.
2. Navy Drug Screening Laboratory (NDSL) Great Lakes: This lab will conduct routine drug screening for more common substances, ensuring full-spectrum detection.

Random Unit Selection Process​

Each month, four units will be chosen randomly, with 15% of each unit's personnel subjected to testing. This equates to approximately 200 personnel tested monthly across all special warfare units. While this number represents only a fraction of the total force, it sends a strong message that no one is exempt from oversight.

Case Study: Kyle Mullen’s Death and Its Impact​

The Navy’s policy shift toward more stringent testing was largely influenced by the death of Kyle Mullen, a 24-year-old Navy SEAL candidate who collapsed during the SEALs’ grueling Hell Week training in 2022. Mullen’s death from acute pneumonia highlighted the dangers of pushing the human body to its limits. Although no evidence of PEDs was found in his system, the discovery of steroids and syringes in his vehicle sparked further scrutiny into the role that PEDs might play in the physical breakdown of candidates during training.

Mullen’s tragic death served as a catalyst for a deeper investigation into the culture of PED use among SEAL candidates, and it reinforced the need for robust testing protocols to ensure that elite warriors are performing at their best naturally, without the aid of dangerous substances.

Moving Forward: Ensuring the Health and Readiness of the Force​

Rear Admiral Keith Davids, commander of Naval Special Warfare Command, has emphasized that the new testing initiative is not just about enforcing rules but about preserving the long-term health and operational readiness of the force. As one of the most elite fighting units in the world, Navy SEALs must maintain the highest standards of physical and mental health to ensure mission success and personal well-being.

The testing program will be funded at approximately $4.5 million annually over the next two years, underscoring the Navy’s commitment to combating PED use. This investment is not just in the technology and resources required for testing but in the very future of the Navy’s special operations forces.

The message from Naval leadership is clear: there is no place for PEDs in the ranks of Navy SEALs. The risks to personal health and team dynamics are too great, and the standards of excellence that define Naval Special Warfare must be upheld at all costs.

Conclusion​

The Navy’s decision to implement random testing for steroids and other PEDs within its special operations forces represents a critical step forward in maintaining the health, readiness, and integrity of the force. As the first military branch to take this groundbreaking measure, the Navy is setting a new standard for addressing the challenges posed by PEDs in elite units.

By emphasizing health, safety, and excellence, the Navy is reaffirming its commitment to the well-being of its personnel and the success of its missions. The program’s rigorous testing protocols and comprehensive approach will serve as a model for other military branches as they consider similar measures to combat PED use among their own special forces.

Through the combination of deterrence, education, and testing, the Navy is poised to protect its warriors from the dangers of PEDs, ensuring that its most elite fighters are operating at their natural best, both now and in the future.